Is the US prepared to deal with another pandemic or widespread health crisis?
Short answer: more prepared than in 2019, but still not where it needs to be. The U.S. can detect and develop countermeasures faster than before, yet funding, workforce, and coordination gaps leave significant vulnerabilities.
What’s stronger now
Where the U.S. is still vulnerable
Bottom line
If you want, I can tailor this to a specific threat (for example, pandemic influenza/H5N1, a novel coronavirus, or a bioterror event) and outline what’s ready versus what isn’t in that scenario.
Citations (11)
- Center for Forecasting and Outbreak Analytics | CFA | CDC
Backs: “Faster outbreak intelligence: the CDC’s forecasting center produces seasonal outlooks and decision support, and national dashboards track hospitalizations for COVID‑19, flu, and RSV.”
- About CDC's Wastewater Monitoring Program | Wastewater Monitoring | CDC
Backs: “Broader pathogen surveillance: the wastewater network now monitors multiple viruses nationwide and, by 2024, was receiving data from 2,300+ sites covering ~54% of the U.S. population.”
- Medical Countermeasures | Influenza & Emerging Infectious Diseases (IED) Pandemic Vaccines & Adjuvants Program
Backs: “BARDA has sustained domestic vaccine manufacturing, a pre‑pandemic influenza vaccine stockpile, and explicit “100‑days” goals to move from sequence to first doses, plus active procurements and prizes to expand H5N1 capacity.”
- Public Health Preparedness: HHS Should Address Strategic National Stockpile Coordination Challenges | U.S. GAO
Backs: “HHS issued clearer roles and procedures for the Strategic National Stockpile in 2025 after GAO findings; the stockpile was substantially replenished after COVID‑19.”
- ASPR Releases the Fiscal Year 2026 / Budget Period 3 Hospital Preparedness Program Continuation Guidance | ASPR
Backs: “ASPR continues the Hospital Preparedness Program (HPP) into FY2026–27 to support healthcare coalitions and surge planning.”
- GAO-25-107743, HIGH-RISK SERIES: Heightened Attention to High-Risk Areas Could Yield Billions in Savings and A More Efficient and Effective Government
Backs: “GAO repeatedly flags HHS emergency leadership as “high‑risk,” and key surveillance like wastewater has faced proposed federal cuts, creating whiplash for state and local systems.”
- 2024 Findings - de Beaumont Foundation
Backs: “Workforce erosion: nationwide surveys show high burnout and significant intent to leave among state and local public health staff, straining response capacity.”
- Public Health Preparedness: HHS Needs a Coordinated National Approach for Diagnostic Testing for Pandemic Threats | U.S. GAO
Backs: “GAO found HHS needs a coordinated, routinely updated national diagnostic testing strategy for emerging threats.”
- GAO-26-107507, PUBLIC HEALTH PREPAREDNESS: Improved Coordination Needed for HHS’s Emergency Preparedness Programs
Backs: “GAO reports HPP/PHEP coordination and performance measurement still need improvement, and inflation‑adjusted HPP resources remain below early‑2000s levels.”
- The Future of PAHPA and National Public Health Preparedness | ASTHO
Backs: “Legal/authority uncertainty: the core preparedness law (PAHPA) has been overdue for full reauthorization since 2023, with many authorities running on short‑term extensions—adding policy risk.”
- Coronavirus (COVID-19) | CBER-Regulated Biologics | FDA
Backs: “End of COVID‑specific flexibilities: the COVID drug/biologic EUA declaration ended June 29, 2026, removing some emergency levers tied to that declaration (new emergencies could still trigger fresh EUAs).”